Sclerosing cholangitis.
D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D001650:Bile Duct Neoplasms / Q000473:pathology; D001799:Blood Sedimentation; D002758:Cholangiography; D002761:Cholangitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000601:surgery; D002769:Cholelithiasis / Q000150:complications; D002779:Cholestasis / Q000209:etiology; D003093:Colitis, Ulcerative / Q000150:complications; D003135:Common Bile Duct / Q000473:pathology; D004912:Erythrocytes; D005260:Female; D006801:Humans; D008297:Male; D011183:Postoperative Complications; D011239:Prednisolone / Q000627:therapeutic use; D012598:Sclerosis / Q000150:complications; D012737:Sex Factors; D014815:Vitamins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D014815:Vitamins; D011239:Prednisolone